Cargando...
Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer’s Disease Diagnosis
An accurate and early diagnosis of Alzheimer’s disease (AD) is important to select optimal patient care and is critical in current clinical trials targeting core AD neuropathological features. The past decades, much progress has been made in the development and validation of cerebrospinal fluid (CSF...
Guardado en:
| Publicado en: | J Alzheimers Dis |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
IOS Press
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5870045/ https://ncbi.nlm.nih.gov/pubmed/29562530 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-170680 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|